Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Interest & Investment Income (2011 - 2026)

Analysis

Cerenome (CNSY) Interest & Investment Income (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 48.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - 35.58 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 5.13 Mn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 10.98 Mn
10 Cerenome 20.42 Mn 11.83 Mn - 56,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56,000.00
Mar 31, 2026 190,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 59,000.00
Jun 30, 2025 27,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 54,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 67,000.00
Mar 31, 2024 72,000.00
Dec 31, 2023 110,000.00
Sep 30, 2023 119,000.00
Jun 30, 2023 120,000.00
Mar 31, 2023 51,000.00
Dec 31, 2022 73,000.00
Sep 30, 2022 48,000.00
Jun 30, 2022 19,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 5,000.00